Australia's Lumos Diagnostics rises on deal to expand medical test-kit sale

Lumos Diagnostics Holdings

18/07/2023 03:41

** Shares of Lumos Diagnostics  LDX.AX  jump as much as
18.2% to A$0.091, their highest since July 10
    ** The company signs an agreement with Henry Schein Medical,
S.L.U. for the FebriDx point-of-care test  
    ** Says the agreement expands Henry Schein's distribution of
FebriDx to include Spain and Portugal
    ** FebriDx is a rapid POC test to differentiate a viral from
bacterial acute respiratory infection
    ** Total 45.7 mln shares change hands, vs 30-day avg volume
of 18.7 mln shares 
    ** Lumos shares up 60.4% YTD, as of last close 
   

 (Reporting by Poonam Behura)
 ((Poonam.Behura@thomsonreuters.com;))